Bill113th Congress

H.R. 1285

To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.

Ask AI
Introduced
Mar 20, 2013
Origin Chamber
House
Policy Area
Crime and Law Enforcement
Latest Action
Apr 15, 2013
Latest Action

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.

Sponsor

Rep. Buchanan, Vern [R-FL-16]

Republican·FL-16
Bioguide ID: B001260
First Name: Vern
Last Name: Buchanan
By Request: N
54
Cosponsors
2
Committees
6
Actions
0
Amendments
1
Related Bills
5
Subjects
1
Summaries
2
Titles
1
Text Versions

Bill Details

Update Date
Jan 5, 2022
Origin Chamber
House
Bill Type
HR
Bill Number
1,285
Congress
113
Introduced Date
Mar 20, 2013
Policy Area
Crime and Law Enforcement
Is Law
No
Apr 15, 2013Committee

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.

Source: House committee actions

Mar 22, 2013Committee

Referred to the Subcommittee on Health.

Source: House committee actions

Mar 20, 2013IntroReferralH11100

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Source: House floor actions

Mar 20, 2013IntroReferralH11100

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Source: House floor actions

Mar 20, 2013IntroReferralIntro-H

Introduced in House

Source: Library of Congress

Mar 20, 2013IntroReferral1000

Introduced in House

Source: Library of Congress

Introduced in House· Mar 20, 20130

Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance.

Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone compound products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date enactment of this Act.

Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including: (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and (2) recommendations necessary to address any issues relating to patient access to adequate pain management.

Judiciary Committee

House· Standing

Energy and Commerce Committee

House· Standing
Drug trafficking and controlled substancesHealth care coverage and accessLong-term, rehabilitative, and terminal carePrescription drugsRural conditions and development

Introduced in House

Mar 20, 2013

VIEW
To amend the Controlled Substances Act to make any substance containing hydrocodone a sche… — Informed